BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37098448)

  • 1. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Porcari S; Baunwall SMD; Occhionero AS; Ingrosso MR; Ford AC; Hvas CL; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103036. PubMed ID: 37098448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
    Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
    Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    Nicholson MR; Alexander E; Ballal S; Davidovics Z; Docktor M; Dole M; Gisser JM; Goyal A; Hourigan SK; Jensen MK; Kaplan JL; Kellermayer R; Kelsen JR; Kennedy MA; Khanna S; Knackstedt ED; Lentine J; Lewis JD; Michail S; Mitchell PD; Oliva-Hemker M; Patton T; Queliza K; Sidhu S; Solomon AB; Suskind DL; Weatherly M; Werlin S; de Zoeten EF; Kahn SA;
    J Crohns Colitis; 2022 Jun; 16(5):768-777. PubMed ID: 34788420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Cho S; Spencer E; Hirten R; Grinspan A; Dubinsky MC
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):343-347. PubMed ID: 30320666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis.
    Tariq R; Syed T; Yadav D; Prokop LJ; Singh S; Loftus EV; Pardi DS; Khanna S
    J Clin Gastroenterol; 2023 Mar; 57(3):285-293. PubMed ID: 34864789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z; Wei W
    Rev Esp Enferm Dig; 2022 Sep; 114(9):543-549. PubMed ID: 35510325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Suchman K; Luo Y; Grinspan A
    Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Recurrent
    Azimirad M; Yadegar A; Gholami F; Shahrokh S; Asadzadeh Aghdaei H; Ianiro G; Suzuki H; Cammarota G; Zali MR
    J Inflamm Res; 2020; 13():563-570. PubMed ID: 32982371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
    van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
    Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
    You JHS; Jiang X; Lee WH; Chan PKS; Ng SC
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1515-1523. PubMed ID: 32017248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
    Patwa SA; Ward C; Kelly CR
    R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
    Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
    Montalto M; Gallo A; Agnitelli MC; Pellegrino S; Lipari A; Pero E; Covino M; Landi F; Gasbarrini A; Cammarota G; Ianiro G
    J Am Geriatr Soc; 2023 Nov; 71(11):3530-3537. PubMed ID: 37458581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.